Compare ADMA Biologics Inc (ADMA) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs McKesson Corporation — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while McKesson Corporation trades at $894.99 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 47.4× ADMA Biologics Inc's market cap, and McKesson Corporation pays a 0.42% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | MCK | |
|---|---|---|
Market Cap | $2.22B | $105.14B |
Sector | Health | Health |
52-Week High | $20.38 | $995.69 |
52-Week Low | $7.60 | $659.01 |
Enterprise Value | $2.29B | $111.67B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
